P53-Suppressed Oncogene TET1 Prevents Cellular Aging in Lung Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-18-1234
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

P53: Oncogene or Anti-Oncogene?

Genes and Development
GeneticsDevelopmental Biology
1990English

DRAM2 Acts as an Oncogene in Non-Small Cell Lung Cancer and Suppresses the Expression of P53

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Interplay Between HSF1 and P53 Signaling Pathways in Cancer Initiation and Progression: Non-Oncogene and Oncogene Addiction

Cellular Oncology
MedicineCancer ResearchOncologyMolecular Medicine
2019English

Significance of Cellular Senescence in Aging and Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2009English

Loss of P53 Attenuates the Contribution of IL-6 Deletion on Suppressed Tumor Progression and Extended Survival in Kras-Driven Murine Lung Cancer

PLoS ONE
Multidisciplinary
2013English

P53 and Angiogenesis in Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

Fenofibrate Prevents Skeletal Muscle Loss in Mice With Lung Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

A First-In-Class TWIST1 Inhibitor With Activity in Oncogene-Driven Lung Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2017English

Restoring LINC00673 Expression Triggers Cellular Senescence in Lung Cancer

RNA Biology
Cell BiologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy